The most frequently reported adverse events were gastrointestinal events, including nausea, vomiting, diarrhea, constipation, or abdominal pain, which affected 79.6% of participants in the cagrilintide-semaglutide group and 39.9% of those in the placebo group
Libove, B.S., Tetyana V
A novel GSH-based topical cream formulation containing N-butanoyl-l-glutathione (GSH-C4), beta-glycyrrhetinic, and azelaic acid may be effective at reducing the number of facial inflammatory lesions and improving symptoms of mild to moderate rosacea when applied once daily, per data from an emerging study
Still, successful regeneration requires not just structural growth but functional integration into existing circuits
Fibroblasts as immune regulators in infection, inflammation and cancer